Lin28 promotes transformation and is associated with advanced human malignancies

Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S, O’Sullivan M, Lu J, Phillips LA, Lockhart VL, et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet. 2009;41:843–8.

NOTES

Viswanathan, Srinivas RPowers, John TEinhorn, WilliamHoshida, YujinNg, Tony LToffanin, SaraO'Sullivan, MaureenLu, JunPhillips, Letha ALockhart, Victoria LShah, Samar PTanwar, Pradeep SMermel, Craig HBeroukhim, RameenAzam, MohammadTeixeira, JoseMeyerson, MatthewHughes, Timothy PLlovet, Josep MRadich, JeraldMullighan, Charles GGolub, Todd RSorensen, Poul HDaley, George Qeng1 R01 DK076986-01/DK/NIDDK NIH HHS/R01 HD052701-02/HD/NICHD NIH HHS/R01 HD052701/HD/NICHD NIH HHS/T32 GM007753/GM/NIGMS NIH HHS/R01 DK076986/DK/NIDDK NIH HHS/DP1 OD000256/OD/NIH HHS/Howard Hughes Medical Institute/T32-HL 66987/HL/NHLBI NIH HHS/DP1 OD000256-01/OD/NIH HHS/Research Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tNat Genet. 2009 Jul;41(7):843-8. doi: 10.1038/ng.392. Epub 2009 May 31.

Abstract

Multiple members of the let-7 family of miRNAs are often repressed in human cancers, thereby promoting oncogenesis by derepressing targets such as HMGA2, K-Ras and c-Myc. However, the mechanism by which let-7 miRNAs are coordinately repressed is unclear. The RNA-binding proteins LIN28 and LIN28B block let-7 precursors from being processed to mature miRNAs, suggesting that their overexpression might promote malignancy through repression of let-7. Here we show that LIN28 and LIN28B are overexpressed in primary human tumors and human cancer cell lines (overall frequency approximately 15%), and that overexpression is linked to repression of let-7 family miRNAs and derepression of let-7 targets. LIN28 and LIN28b facilitate cellular transformation in vitro, and overexpression is associated with advanced disease across multiple tumor types. Our work provides a mechanism for the coordinate repression of let-7 miRNAs observed in a subset of human cancers, and associates activation of LIN28 and LIN28B with poor clinical prognosis.
Last updated on 02/17/2021